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effector caspase-3, -6, and -7. However, some of the
“apoptotic” caspases, in particular caspase-8, have
been recently shown to have additional roles in prolifera-
tion and differentiation. For example, caspase-8 activity
appears to be necessary for lymphocyte proliferation
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Switzerland (Chun et al., 2002; Salmena et al., 2003).
Human caspase-1, -4, and -5 and mouse caspase-11
and -12 constitute another group, the caspase-1 sub-
family (Figure 1A). The in vitro substrate preferences ofCaspases not only play an essential role during apoptotic
cell death, but a subfamily of them—the inflammatory caspase-1, -4, and -5 have been determined using small
peptides, and they were found to be similar. One pre-caspases—are associated with immune responses to
microbial pathogens. Activation of inflammatory cas- ferred sequence is WEHD (Garcia-Calvo et al., 1998).
Although there is some evidence that these caspasespases, such as caspase-1 and caspase-5, occurs upon
assembly of an intracellular complex, designated the can be involved in apoptosis, their prime function is the
regulation of inflammatory processes; for this reason,inflammasome. This results in the cleavage and activa-
tion of the proinflammatory cytokines IL-1 and IL-18. these evolutionarily related caspases are designated
inflammatory caspases. Phylogenetically, caspase-14Mutations in one of the scaffold proteins of the inflam-
masome, NALP3/Cryopyrin, are associated with au- and caspase-2 are close to the inflammatory subgroup
(Figure 1A). They have been implicated in keratinocytetoinflammatory disorders underscoring the impor-
tance of regulating inflammatory caspase activation. differentiation (Eckhart et al., 2000) and stress-induced
apoptosis, respectively (Lassus et al., 2002; Tinel and
Tschopp, 2004).Caspases: Executioners of Apoptosis,
Inflammation, and More Here we review the current understanding of the acti-
vation mechanisms and role of inflammatory caspases.Caspases are a family of cysteine proteases that fulfill
critical roles in mammalian apoptosis or proteolytic acti- We particularly focus on complexes that activate cas-
pase-1 and on the biological consequences, which re-vation of cytokine (for reviews, see Boatright et al., 2003;
Nicholson, 1999; Shi, 2002). Caspases generally recog- sult from caspase-1-mediated activation of IL-1.
nize a tetrapeptidic sequence and have a stringent spec-
ificity for cleaving the peptide bond C-terminal to aspar- Inflammatory Caspases
tic acid residues. Currently, 13 caspases have been Inflammatory caspases have so far only been found in
identified in mice and humans and these represent at vertebrates. In zebrafish and pufferfish, two subgroups
least 11 different activities. Whereas caspases 1–3, 6–9, of inflammatory caspases with a highly conserved cas-
and 14 are present in mice and humans, human cas- pase domain, but distinct N-terminal prodomains, can
pase-4 and -5 have no known counterparts in mice; be found (Figure 1B). The first subgroup is formed by
conversely, caspase-11 and -12 have no known counter- Caspy-1 and Caspy-2, which both contain an N-terminal
parts in humans (Lamkanfi et al., 2002). A caspase-12 Pyrin domain (see below), whereas a third predicted
sequence is present in the human genome but does not inflammatory caspase contains a caspase-recruitment
seem to be able to encode an active enzyme (see below) domain (CARD) at the N terminus. Although the function
(Fischer et al., 2002; Saleh et al., 2004). of these fish caspases is ill defined, they appear to be
Caspases can be subdivided into initiatior and ef- essential for morphogenesis of the jaw and gill-bearing
fector caspases. The subset of caspases that cleave arches (Masumoto et al., 2003).
selected substrates to produce the changes associated In mammals, there are five inflammatory caspases
with apoptosis are known as effector caspases, which that all have a CARD at their N terminus (Figure 1B).
in mammals are caspase-3, -6, and -7. In most instances, Human inflammatory caspases are clustered on chro-
these executioner caspases are activated by the initiator mosome 11q22 in the following order from the telomere:
caspases, i.e., caspase-8, caspase-10, caspase-2, and caspase-1, caspase-5, caspase-4, and finally the gene
caspase-9. Other initiator caspases are caspase-1, cas- for caspase-12 (Figure 1C). The organization of the syn-
pase-4, caspase-5, and most likely caspase-14. Unlike tenic region in mice is similar, except that the caspase-5
the dimeric effector caspases, initiator caspases, except and caspase-4 genes are replaced by the caspase-11
for caspase-14, contain a large prodomain that links the gene (Figure 1B). Two inhibitors of caspase-1, ICEBERG
caspase to the molecular machinery that is responsible and COP (pseudo-ICE) (Druilhe et al., 2001; Humke et
for their activation. al., 2000; Lee et al., 2001), which both consist of a single
The phylogenetic relationship of caspases appears to CARD domain (see below), are found in the same locus
correlate with their function (Lamkanfi et al., 2002). One in humans, but interestingly are absent from the mu-
subfamily of caspases is constituted by caspases that rine locus.
have clear functions in the execution of apoptosis and Caspase-1 (Human and Mouse)
includes the initiator caspase-8, -9, and -10 and the Caspase-1 is the best-characterized inflammatory cas-
pase. Caspase-1 was originally identified as a result
of attempts to purify the enzyme responsible for the*Correspondence: jurg.tschopp@ib.unil.ch
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Figure 1. Inflammatory Caspases
(A) Based on the phylogentic analysis of the caspase domain, caspases segregate into two major subfamilies, the apoptotic caspases (caspase-8,
-10, -9, -3, -6, and -7) and the inflammatory caspases (caspase-1, -4, -5, -11, and -12). Caspase-2 and caspase-14 form their own cluster.
(B) Domain structure of human, murine, and zebrafish inflammatory caspases. CARD, caspase-recruitment domain; PYD, Pyrin domain.
(C) Chromosomal organization of inflammatory caspases.
processing of proIL-1 (Thornberry et al., 1992). IL-1 efficient expression of IL-1, for reasons that remain
unclear (Kuida et al., 1995; Li et al., 1995). In contrastmRNA encodes a cytosolic 33 kDa proIL-1 protein that
requires proteolytic cleavage in order to be secreted to IL-1, IL-1 is thought to be cleaved by calcium-
dependent calpain proteases, to yield a 17 kDa matureand to function as an active protein. Cleavage occurs
at the site Tyr-Val-His-Asp116/Ala117 (Cameron et al., 1985; peptide (Kobayashi et al., 1990).
Early studies with caspase-1 demonstrated that cas-March et al., 1985) giving rise to the 17 kDa C-terminal
mature cytokine. A technical breakthrough in the identifi- pase-1, when overexpressed in fibroblasts, can induce
apoptosis, suggesting a role for caspase-1 also in cellcation of the mechanisms of proIL-1 maturation was
provided by the establishment of an in vitro assay of death (Miura et al., 1993). However, caspase-1-deficient
mice, while deficient in the processing of proinflamma-proIL-1 maturation (Kostura et al., 1989), in which ma-
ture IL-1 was generated by incubation of proIL-1 with tory cytokines, show no overt defect in apoptosis (Kuida
et al., 1995; Li et al., 1995). Nevertheless, caspase-1extracts from hypotonically lysed human monocytes.
This allowed the characterization of the IL-1 converting appears to be involved in some forms of neuronal cell
death. Mutant caspase-1 that lacks an active site inhibitsenzyme (ICE), nowadays known under the name of cas-
pase-1 (Cerretti et al., 1992; Miller et al., 1993; Thorn- trophic factor withdrawal-induced apoptosis in dorsal
root cells (Friedlander, 2003). Brain injury induced byberry et al., 1992).
The requirement for caspase-1 in IL-1 maturation middle cerebral artery occlusion, a mouse model of
stroke, is significantly reduced in caspase-1-deficientwas revealed by the generation of mice deficient in cas-
pase-1 (Kuida et al., 1995; Li et al., 1995). These mice mice (Friedlander, 2003; Schielke et al., 1998).
Caspase-11 (Mouse)have a defect in the maturation of proIL-1 and are
resistant to the lethal effect of endotoxins. Murine caspase-11 is another partially characterized
member of the inflammatory caspase subfamily. MiceIn addition to the processing of IL-1, caspase-1 acti-
vates another proinflammatory cytokine, IL-18, that is deficient in caspase-11 have a strikingly similar pheno-
type to caspase-1-deficient mice; for example, caspase-also known as interferon--inducing factor (Gracie et
al., 2003). Furthermore, caspase-1 is required for the 11-deficient mice are resistant to endotoxic shock in-
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duced by bacterial lipopolysaccharide (LPS) and fail to to a progressive depletion of ER Ca2 (Zong et al., 2003).
produce mature IL-1 after LPS stimulation (Wang et It has been proposed that the high Ca2 levels result in
al., 1998). Caspase-11-deficient embryonic fibroblasts the activation of calpain that subsequently processes
are resistant to apoptosis induced by ectopic expres- caspase-12 (Nakagawa et al., 2000). Activation of cas-
sion of caspase-1, suggesting that caspase-1 is an up- pase-12 through clustering by TRAF2, a protein impli-
stream activator of caspase-11, most likely by a direct cated in the activation of the transcription factor NF-B,
physical interaction (Wang et al., 1998). Caspase-11 may has also been reported (Yoneda et al., 2001).
play a role in the etiology of multiple sclerosis since In humans, a polymorphism in caspase-12 results in
oligodendrocytes from caspase-11-deficient mice are the production of either a truncated CARD-only protein
partially resistant to cytokine-induced cell death (Hisa- or a full-length caspase molecule (Casp12-L), which,
hara et al., 2001). In contrast to caspase-1, the expres- however, appears to be enzymatically inactive (Saleh et
sion of caspase-11 is LPS inducible (Wang et al., 1998) al., 2004). The full-length variant molecule is entirely
and regulated by p53 (Choi et al., 2001). confined to populations of African descent and confers
Caspase-5 and Caspase-4 (Human) hypo-responsiveness to LPS-mediated production of
Based on its expression pattern and sequence homology, cytokines such as IL-1 and INF. Thus, caspase-12
caspase-5 was proposed to be the human ortholog of in human appears to function as a dominant-negative
caspase-11 (Lin et al., 2000). Like caspase-11, protein regulator of proinflammatory signaling pathways, in-
levels of caspase-5 are increased by LPS (Lin et al., 2000). cluding the IL-1 and NF-B pathways, thereby modulat-
Moreover, caspase-5 is involved in IL-1 processing ing inflammation. In this function, it is more related to
and can interact with caspase-1 (Martinon et al., 2002). the CARD-only proteins ICEBERG and COP (see below).
Both caspase-1 and caspase-5 are constituents of the Unexpectedly, the frequency of the Casp12-L allele is
NALP1 inflammasome, a complex that can trigger cleav- elevated in African American patients with severe sep-
age of proIL1- (see below). However, the situation is sis, which is believed to be linked to an increased rather
probably more complex. It is likely that caspase-4 and than to a decreased inflammatory cytokine response.
caspase-5 arose from the gene duplication of a cas- Thus, the exact role of the two human caspase-12 forms
pase-11-like ancestral gene. Frameshift mutations of in innate immunity and inflammation requires further in-
caspase-5 are frequently found in endometrial carci- vestigation.
noma (Schwartz et al., 1999). Moreover, caspase-5 Not surprisingly, considering the absence of catalytic
cleaves Max, a component of the Myc/Max/Mad net- activity, the presence of Casp12-L has no effect on apo-
work of transcription factors that is frequently deregu- ptosis. It is therefore possible that the function of
lated in tumors (Krippner-Heidenreich et al., 2001), sug- murine caspase-12 is fulfilled in humans by one or more
gesting a regulatory role of caspase-5 in tumorigenesis. of the inflammatory caspases such as caspase-4 or cas-
Virtually nothing is known on substrates and expres- pase-1, yet this has to be demonstrated. This hypothesis
sion of the second possible human ortholog of murine is supported by the fact that inflammatory caspases
caspase-11, i.e., caspase-4, except that the transcrip- other than caspase-12 also appear to be involved in ER
tion of this caspase is induced by interferons (Ahn et stress-induced apoptosis in mice since mouse mela-
al., 2002) and that the caspase is activated when cells noma cells die when treated with ER stress-inducing
are treated with agents stressing the endoplasmic retic- agents, whether they express caspase-12 or not (Kalai
ulum (ER) (Hitomi et al., 2004). et al., 2003).
Caspase-12 (Human and Mouse)
Rather than revealing a role in inflammatory processes,
Activation of Initiator Caspases:study of the caspase-12-deficient mice suggests its
The Caspase-Activating Platforminvolvement in ER-stress-induced apoptosis, which is
There is ample biochemical and structural evidence thatfrequently due to accumulation of misfolded proteins
active caspases are obligate dimers with two identicaland changes in calcium homeostatsis (Morishima et al.,
catalytic sites. Unlike the zymogen form of effector cas-2002; Nakagawa et al., 2000; Rao et al., 2002). Caspase-
pases that exist as preformed dimers and that are acti-12-deficient thymocytes are slightly resistant to agents,
vated by specific proteolytic cleavage in the linker regionsuch as brefeldin A, that induce ER stress, but they still
between the large and the small subunit (Boatright anddie from other death stimuli and process IL-1 normally.
Salvesen, 2003), initiator caspases exist within the cellMoreover, cortical neurons become partially resistant
as inactive monomers. Although it was generally as-to amyloid- protein but not to staurosporine. In its role
sumed that initiatior caspases also require proteolyticas ER stress sensor, caspase-12 appears to participate
processing, recent work has revealed that cleavage isin the development of neurodegenerative disorders like
not essential for activation (Boatright et al., 2003; Mi-Alzheimer’s disease or pathological prions-induced
cheau et al., 2002). Rather, the monomeric inactive pre-apoptosis (Hetz et al., 2003; Nakagawa et al., 2000).
cursors only require dimerization (or oligomerization) toCell death in the absence of caspase-12 is never com-
assume an active conformation. Further processing ofpletely blocked, suggesting a certain degree of redun-
the initiator caspases plays a role in the stabilization ofdancy. ER stress can cause mitochondrial damage and
the active enzyme (Boatright et al., 2003; Rodriguez andthus activation of the apoptosome; however, an Apaf-
Lazebnik, 1999). Dimerization of initiator caspases is1-independent pathway has been proposed in which
triggered by specialized multimeric platforms that allowcaspase-12 activates caspase-9 and subsequently cas-
recruitment of multiple caspase molecules into a com-pase-3 (Bitzer et al., 2002; Morishima et al., 2002; Rao et
plex. This brings initiator caspases into close proximity,al., 2002). ER stress can induce conformational changes
and oligomerization of Bax and Bak on the ER leading provoking their activation.
Cell
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Figure 2. The Caspase-Activating Platforms
(A) Platform proteins generally consist of a ligand sensing domain (frequently repeats of domains, the structure of leucine-rich repeats, LRR
is shown), a nucleotide binding oligomerization domain (NOD, AAA cassette; NB-ARC, NACHT), and a recruitment domain (DD, DED,
CARD, PYD).
(B) Examples of known caspase-activating platforms. Note that NOD2 activates a kinase (RIP2) and not a caspase. DD, Death domain; DED,
Death effector domain; CARD, caspase-recruitment domain; PYD, pyrin domain; NACHT, NAIP, CIITA, HET-E, TP1 domain; NAD, NACHT-
associated domain.
The structural organization of such a caspase-activat- mann, 1999). There are no cross interactions between
family members.ing scaffold molecule has to fulfill three criteria (Figure
2A). First, it contains a region that can interact directly A second structural feature of the caspase-activating
platform is the presence of an oligomerization motif thator indirectly with the prodomain of the initiator caspases.
Since prodomains of initiator caspases are domains of facilitates the formation of dimers or oligomers. In the
few examples of caspase-activating scaffolds known,the death-fold (DF) family, the domain found in the cas-
pase-activating platform always contain such a DF do- this motif is a NACHT domain or the closely related NB-
ARC motif (see below). Both domains can bind nucleo-main. The DF superfamily contains four distinct mem-
bers: The death domain (DD), the death-effector domain tides and are therefore called NBS (nucleotide binding
site) domains or NOD (nucleotide binding oligomeriza-(DED), the CARD domain, and the Pyrin domain (PYD).
Structurally, they are characterized by six  helices that tion domain). NODs contain P loop and Walker boxes
that are conserved in nucleotide binding motifs. Struc-are tightly packed in a Greek key fold (Fesik, 2000).
Proteins containing a DF domain bind to another mem- tural alignments clearly demonstrate that NODs are
members of the AAA (ATPase associated with diverseber of the same family via homotypic interactions (Hof-
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cellular activities) family (Jaroszewski et al., 2000), which names include CATERPILLAR, PAN, PYPAF family) (Har-
ton et al., 2002; Inohara and Nunez, 2001; Tschopp etcontains a conserved ATPase domain, typically span-
al., 2003). Based on the phylogenetic analysis, the NOD-ning 200–250 residues, referred to as the AAA cassette
LRR family is separated into several distinct subfamil-(Neuwald et al., 1999). In general, AAA proteins form
ies—the CIITA, NOD, Ipaf, and NALP subfamilies (Ino-oligomeric structures involved in supporting large mo-
hara and Nunez, 2003; Tschopp et al., 2003). As expected,lecular complexes (Figure 2A). Most of these proteins
the NOD-LRR proteins show a structural homology toare involved in assembly of wheel-like structures with
Apaf-1, but interestingly, also to disease-resistancea 6-fold or 7-fold symmetry with an active hub in the
genes of plants (R proteins) that upon viral infectioncenter, which is generally used to recruit and process
mediate the hypersensitive response leading to local-their targets. For example, many AAA accommodate
ized cell death (Holt et al., 2003). Members of the NOD-DNA and are involved in DNA recombination, DNA repair,
LRR family contain either a CARD or a PYD caspaseand transcription, while others recruit proteins and in-
interaction motif and a typical NACHT oligomerizationduce their cleavage, degradation, or refolding (Ogura
domain (Figure 2B). Their ligand sensing domain is com-and Wilkinson, 2001). Cryoelectron microscopy pro-
posed of LRRs. LRRs are relatively short motifs (22–28vided evidence that the apoptosome is a typical AAA
residues in length) that are known to provide a versatilecomplex used for caspase-9 activation (Acehan et al.,
structural framework for the formation of protein-protein2002). Mutations in AAA cassettes are found to be the
or protein-carbohydrate/lipid interactions (Kobe and Ka-cause of several disorders. For example, mutations in
java, 2001). The structure of a ribonuclease inhibitor, aspastin are associated with neurodegenerative disor-
protein containing 15 LRRs, has been determined re-ders (Hazan et al., 1999), and NOD2 and NALP3 (Pypaf1,
vealing LRRs to be a new class of / fold (Figure 2A)Cryopyrin, CIAS1) are both mutated in the NOD/AAA
(Kobe and Deisenhofer, 1993). The structural units arecassette in autoinflammatory disorders (see below).
organized in a nonglobular, horseshoe-shaped moleculeThe third structural requirement of a caspase-activat-
(Figure 2A). The inner circumference forms the liganding platform is the presence of a domain that regulates
binding region. Since LRRs of Toll-like receptors (TLRs)its activity. Caspase-activating platforms are typically
recognize various bacterial and viral substances, includ-present in the cytoplasm as inactive monomers and
ing LPS, it is likely that they also serve for the detectionoligomerize only upon reception of a specific signal,
of pathogen-derived molecules in members of the NOD-through binding of a ligand. This ligand sensing domain
LRR family. Indeed, LRRs of the two NOD-LRR familyis composed of multiple repeats of motifs such as leu-
members NOD1 and NOD2 (Figure 2B) detect the pres-cine-rich repeats (LRR) or, in the case of Apaf-1, WD40
ence of bacterial muropeptides (Chamaillard et al.,repeats (Figure 2A). In the absence of the activating
2003). Overexpression of NOD1 and NOD2 induces theligand, the C-terminal segments intramolecularly inter-
activation of NF-B, an activity that requires the CARDsact with the NOD/AAA motif, thereby inhibiting oligo-
and correlates with the ability of NODs to associatemerization and thus spontaneous activation of the plat-
with the CARD-containing serine-threonine kinase RIP2form. Thus, in the absence of an activating signal,
(Ogura et al., 2001b).caspase-activating platforms are kept in an inactive
Caspase-1-Activating NOD-LRR Members:conformation.
Ipaf and NALPsThe best characterized capase activation platform is
Members of two subgroups of the NOD-LRR family haveApaf-1, which is the scaffold of the apoptosome (Figure
been proposed to play a role in the activation of inflam-2B) (Zou et al., 1997). Many proapoptotic stimuli provoke
matory caspases. Ipaf associates with caspase-1 andthe release of cytochrome c from mitochondria, which
activates caspase-1 upon overexpression (Figure 3)subsequently binds to the WD40 domain of Apaf-1. In
(Damiano et al., 2001; Geddes et al., 2001; Poyet et al.,the presence of dATP, Apaf-1 undergoes conforma-
2001). It will be interesting to see whether further analy-
tional changes. Assembly of the heptameric caspase-
sis at physiological levels of Ipaf supports a role of this
activating complex occurs through the NBS/NOD do-
protein as a caspase-1-activating protein.
main, with subsequent recruitment and activation of By far the largest subgroup of the NOD-LRR family
caspase-9 via its N-terminal CARD domain. is represented by 14 proteins designated NALPs (or
A variation of the caspase-activating scaffold model PYPAFs) (Tschopp et al., 2003). NALPs display the fol-
occurs when death receptors, such as Fas, activate initi- lowing tripartite structure: PYD-NACHT-LRR (Figure 2B).
atior caspases (Figure 2B). Death receptors can be con- NALP1 (DEFCAP, NAC, CARD7) contains in addition a
sidered as ligand-sensing domain that upon binding to FIIND (F-interacting domain) and a CARD motif at its C
the death ligands oligomerize and recruit the initiatior terminus (Figure 3). As NALPs have been discovered
caspase-8 and caspase-10 via the DD-DED containing only recently, the information about their function, ex-
adaptor protein FADD, forming the so-called death- pression, and binding partners is relatively scarce
inducing signaling complex (DISC). (Tschopp et al., 2003). Nonetheless, there is now con-
vincing evidence that several of the NALPs are impli-
Activation Scaffolds of Proinflammatory cated in caspase-1 (and caspase-5) activation. NALP1,
Caspases: The NOD-LRR Family NALP2, NALP3, NALP6 (PYPAF5), and NALP12 (PYPAF7,
To identify additional caspase-activating platforms, ge- Monarch-1) were shown to bind ASC and activate cas-
nomic databases were searched for the presence of possi- pase-1 upon overexpression, suggesting that several
ble candidates that fulfill the structural criteria defined NALPs may constitute platforms for the assembly of
above. This led to the identification of a novel family inflammasome-like complexes (see below). However,
NALPs may also fulfill other functions. Embryos ofof proteins designated the NOD-LRR family (alternative
Cell
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Figure 3. The Inflammasomes
Unknown exogenous (from bacteria) or endogenous (bacteria, viruses—“danger signals”) ligands bind to the LRRs of NALPs and induce
assembly of the complex. See text for further details. FIIND, F-interacting domain.
NALP5 (Mater)-deficient mice die at the two-cell embryo pase-1 are therefore brought into close proximity,
thereby facilitating crossactivation.stage, suggesting that NALP5 has an essential role in
cell viability (Tong et al., 2000). The most efficient system used to study inflamma-
some assembly at the endogenous level is the cell free
system originally used to isolate active caspase-1/ICE.The Inflammasome
NALP1 is the only family member with a carboxy-termi- This system is amenable to immunodepletion. Removal
of ASC showed the critical role of ASC in inflammasomenal extension containing a FIIND and a CARD (Figure
3). Four splice variants of human NALP1 exist, one of assembly since it abolished caspase-1 and caspase-5
activation (Martinon et al., 2002). This is in accord withwhich does not contain a CARD domain (Hlaing et al.,
2001). NALP1 messenger RNA is found in the heart, the observation that a dominant-negative version of ASC
(containing only the PYD domain) blocked LPS-inducedthymus, spleen, kidney, liver, lung, and peripheral blood
lymphocytes (Chu et al., 2001). NALP1 was initially re- IL-1 maturation in THP-1 cells and that inhibition of
ASC expression by siRNA abolished NALP3-inducedported to induce apoptosis either through a direct asso-
ciation with caspase-2 and caspase-9 (Hlaing et al., IL-1 secretion (Dowds et al., 2004).
ASC was initially identified as a detergent-insoluble2001) or indirectly through an interaction with Apaf-1
and subsequent enhancement of apoptosome function protein that forms filament-like structures (specks) in
cells that are undergoing apoptosis induced by retinoic(Chu et al., 2001). However, recent evidence shows that
NALP1 is the activating platform of a multiprotein com- acid (Masumoto et al., 1999). ASC protein levels are
increased in neutrophils at sites of severe inflammationplex, called the inflammasome (Martinon et al., 2002)
(Figure 3). In this complex, NALP1, via its N-terminal (Shiohara et al., 2002). ASC expression is also regulated
at the genomic level through promoter methylation.PYD, recruits the adaptor protein ASC, which is a bipar-
tite protein containing a PYD and a CARD. The CARD ASC/TMS1 (“target of methylation-induced silencing”)
was identified to be aberrantly methylated and silencedregion of ASC then interacts with and activates cas-
pase-1. In addition, NALP1 binds and activates cas- in human breast cancer cells (Conway et al., 2000;
McConnell and Vertino, 2004). In addition, ASC expres-pase-5 through the C-terminal CARD domain. In the
NALP1 inflammasome complex, caspase-5 and cas- sion is regulated by p53 (Ohtsuka et al., 2004). The struc-
Review
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ture of the PYD of ASC was shown to be similar to the that the mechanisms that lead to the activation of cas-
pase-1 in the cell free system and following ATP stimula-PYD of NALP1 (Hiller et al., 2003; Liepinsh et al., 2003),
revealing a local unfolding of the third of the six helices tion are similar. However, the physiological relevance
of this mechanism, especially in the case of IL-1 matu-typical of the DF domains (Hiller et al., 2003).
Akin to NALP1, NALP3 binds ASC and activates cas- ration induced by bacterial products, is unclear.
Hence, at least two mechanisms are able to triggerpase-1. NALP3 expression is restricted to immune cells
(Hoffman et al., 2001; Wang et al., 2002). Four splice activation of caspase-1, one as a consequence of a
bacterial product and the other following changes in thevariants have been described, one of which lacks all
LRRs (Aganna et al., 2002; O’Connor et al., 2003). How- intracellular ionic environment. Whether both pathways
trigger activation of the same inflammasome complexever, even the longest one is devoid of the FIIND and
the CARD present in NALP1. Interestingly, a protein with remains to be established.
a domain organization corresponding to this unique car-
boxyl terminus, designated Cardinal (TUCAN, CARD8, Inhibitors of Caspase-1 Activation
NDDP1), has been identified (Figure 3) (Bouchier-Hayes Although the production of IL-1 is critical for the control
et al., 2001; Pathan et al., 2001; Razmara et al., 2002). of pathogenic infections, excessive cytokine production
Not surprisingly therefore, Cardinal was found to be a is harmful to the host and can even be fatal. It is therefore
constituent of the NALP3 inflammasome, which, like the not surprising that several safeguards control the activ-
NALP1 inflammasome, spontaneously assembles in cell ity of IL-1, including the regulation of gene expression,
extracts of THP-1 cells (Agostini et al., 2004). Formation synthesis, secretion, and receptor association (reviewed
of a complex consisting of NALP3, ASC, caspase-1, and in Dinarello, 1997). IL-1mRNA is absent from cells until
Cardinal, but not caspase-5, is detectable (Figure 3). stimulated by extracellular signals. Various inflamma-
This is in agreement with the observation that Cardinal tory stimulators like endotoxins, TNF, or phorbol ester
does not activate caspase-5 upon overexpression, while (PMA) induce the synthesis of IL-1. The transcription
moderate activation of caspase-1 occurs (Agostini et factor NF-B plays an important role in the synthesis
al., 2004). Thus, in contrast to the NALP1 inflammasome, of IL-1. Besides maturation of the inactive proIL1-
the NALP3 inflammasome activates only caspase-1. The precursor by caspase-1, its activity is further controlled
importance of the NALP3 inflammasome in inflammation by a still ill-defined process of secretion. All members
became apparent with the discovery that mutations of of the IL-1 family lack a signal sequence and are trans-
the NALP3 gene are associated with autoinflammatory lated in the cytoplasm (Auron et al., 1987). Mature IL-1
diseases (see below). was found in vesicles that share similarities with late
Like NALP3, NALP2 (PYPAF2, NBS1, PAN1) also forms endosomes (Andrei et al., 1999), suggesting a novel
a Cardinal-containing inflammasome that acts as a plat- function for this cellular compartment. Recently, mono-
form for the activation of caspase-1 (Agostini et al., cytes stimulated extracellularly with ATP were shown
2004). In addition to their role as activators of inflamma- to release microvesicules containing active IL-1 (Mac-
tory caspases, several of the NALPs modulate cytokine- Kenzie et al., 2001), but the biological relevance of this
induced NF-B activation (Fiorentino et al., 2002; O’Con- shedding is still controversial (Verhoef et al., 2003). Un-
nor et al., 2003). expectedly, the activated caspase-1 and -5 and possible
other components of the inflammasome are rapidly and
specifically released along with mature IL-1 into theActivation of Inflammasomes
Little is known about the natural stimuli that lead to the supernatant, at least in THP-1 cells following LPS stimu-
lation (Martinon et al., 2002). The secretion of activatedassembly of complexes activating inflammatory cas-
pases. The only physiological stimulus that is reported caspase-1 and -5 may also be a means of negatively
regulating IL-1 processing. Secretion has not been ob-to activate caspase-1 in phagocytes is LPS (Chin and
Kostura, 1993; Schumann et al., 1998; Wewers et al., 1999). served for other activated caspases, and this may ex-
plain why proinflammatory caspases are generally notVery few studies extended this model of caspase-1 activa-
tion, mainly because it only induces moderate caspase-1 proapoptotic. Secretion of activated caspase-1 and-5
may therefore also be required for a macrophage toactivity. The stimulus downstream of LPS interaction
with its cognate receptor TLR-4 is not known. At present, survive.
To this list of regulatory mechanisms controlling IL-1it cannot be excluded that LPS enters the cell and di-
rectly interacts with the LRR of NALPs, similar to the activity must be added several proteins that interfere
with the activity of caspase-1. These proteins includeproposed model of activation of NODs by bacterial
muropeptides. COP (Pseudo-ICE), DASC (POP1), ICEBERG, and pro-
teinase inhibitor 9 (PI-9), the latter two being inducibleThe best-studied model of caspase-1 activation re-
lates to the exposure of cells to extracellular ATP acting by proinflammatory agents (i.e., LPS and TNF) and there-
fore being part of a negative feedback loop (Figure 4B).on P2X7 receptors. P2X7 receptors belong to a family of
ion channel receptors gated by extracellular ATP and Human caspase-12 may also be included in this inven-
tory since at least the long form decreases LPS-inducedwidely distributed in non-neuronal cells (North, 2002).
The open channel is permeable to larger cations includ- IL-1 maturation (Saleh et al., 2004).
Both COP and ICEBERG contain CARD domainsing calcium and potassium. Many studies have shown
the requirement of P2X7 receptors for ATP-induced cas- closely resembling the prodomain of caspase-1. Via
CARD-CARD interactions, it is predicted that COP andpase-1 activation and subsequent IL-1 release (Labasi
et al., 2002; Solle et al., 2001). As P2X7 receptor activa- ICEBERG negatively regulate proIL-1 processing by
preventing direct interactions between the adaptor(s)tion mimics a hypotonic stress situation, it is possible
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Figure 4. Mutations in NALP3 Found in Inflammatory Disorders
(A) Model of the NACHT domain of NALP3. Mutations found in the inflammatory diseases MWS, FCU, and CINCA are indicated.
(B) The R260W is not only mutated in NALP3 but also at the corresponding position in the NACHT of NOD2 (R334) in Blau syndrome.
(C) NALP3 signaling pathway. The NALP3 inflammasome is activated by an unknown ligand, which leads to the activation of caspase-1 and
subsequent processing of IL-1. Inflammasome activation is inhibited by Pyrin (mutated in familial Mediterranean fever [FMF]), which interacts
with PSTPIP1 (mutated in PAPA). Caspase-1 activation is inhibited by the CARD containing ICEBERG, COP, and DASC (POP1) and possibly
by (human) caspase-12. Further downstream, active caspase-1 is blocked by PI-9 and finally, IL-1 activity is inhibited by IL1Ra.
and caspase-1/5 oligomerization (Druilhe et al., 2001; 1Ra), IL-18, and six additional, newly discovered mole-
cules with clear similarity but poorly characterized func-Green and Melino, 2001; Lee et al., 2001).
In a similar manner, DASC (POP1) may block caspase-1 tion (Taylor et al., 2002). IL-1 and IL-1 have similar
biological activities in vitro and activate the same mem-activation. DASC has high homology to the PYD of ASC
but lacks the C-terminal CARD domain of ASC. By bind- brane receptors on the targeted cells. On the other hand,
IL-1 is more important for the development of fevering NALP1, DASC therefore blocks caspase-1 recruitment
to the inflammasome (Stehlik et al., 2003). In contrast in vivo (Fantuzzi, 2001). IL-18 was first described as an
endotoxin-induced factor that stimulates the productionto the above negative regulators, PI-9 inhibits caspase-1
activation by blocking its active site (Annand et al., of interferon- by splenocytes. However, IL-18 has many
other functions, including induction of proinflammatory1999).
cytokines, upregulation of adhesion molecules, and acti-
vation of natural killer cell activity (Gracie et al., 2003).Biological Activities of IL-1, the Prime Substrate
of Caspase-1 IL-1 is one of the key mediators of the body’s re-
sponse to microbial invasion, inflammation, immunolog-The two key substrates of caspase-1, IL-1 and IL-18, are
major mediators of inflammation and in general initiate ical reactions, and tissue injury. IL-1 affects a large
range of cells and organs. Induction of secondary cyto-and/or increase a wide variety of effects associated with
innate immune defenses. The IL-1 family has ten members kines, including IL-6, CSF, and chemokines, is involved
in many of the in vitro and in vivo actions of IL-1 (Dina-that are well characterized and display important biologi-
cal functions: IL-1, IL-1, IL-1 receptor antagonist (IL- rello, 1997).
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It is now clear that the main endogenous pyrogen is NALP3/Cryopyrin/CIAS1 (Cuisset et al., 1999; McDer-
mott et al., 2000). Subsequently, several point mutationsIL-1. In addition to fever, IL-1 has other effects on
in the NALP3 gene were found not only in MWS andthe CNS. These include induction of slow-wave sleep,
FCU, but also in CINCA (Figure 4A). More than 42 familiesanorexia, and pain hypersensivity, typically associated
have been characterized to date with 23 different muta-with infections or injury (Krueger and Majde, 2003; Sa-
tions. Some NALP3/Cryopyrin mutations can give risemad et al., 2001).
to various symptoms. For example, the R260W mutationIL-1 has a number of local effects that have been
is present in patients with characteristics of MWS ortermed “catabolic” and play a role in destructive joint
FCU and the T348M mutation in patients with MWSand bone diseases. In particular, IL-1 induces produc-
or CINCA. No single mutation results in both FCU andtion of collagenase by synovial cells and of metallopro-
CINCA. The Y570C and F523L mutations are reportedteinases by chondrocytes. Another important action of
only in CINCA patients (Hoffman et al., 2003). The mostIL-1 is its toxicity for neurons, and it may therefore be
frequent mutation is R260W (Figure 4B). All these muta-involved in acute neurodegeneration and stroke (Roth-
tions are found in exon 3 that encodes the NACHT andwell et al., 1997).
NAD (NACHT-associated domain) motifs of NALP3 (Fig-
ure 4B). It is noteworthy that Blau syndrome, which isAutoinflammatory Diseases:
an autosomal-dominant disease characterized by syno-The NALP3 Connection
vitis, arthrocutaneouveal granulomatosis, and cranialConsidering the key role of IL-1 in inflammatory pro-
neuropathies, is caused by mutations in the NACHTcesses, it is not surprising that defective control of in-
domain of NOD2 (Miceli-Richard et al., 2001) that corre-flammasome activity can cause serious inflammatory
spond to the mutation R260W (Figure 4B). Mutations indiseases. Inflammatory disorders cover a variety of re-
the NOD2 gene are also associated with susceptibilitylated pathologies. The best known are the autoimmune
to Crohn’s disease (Hugot et al., 2001; Ogura et al.,disorders, which generally arise from autoreactive
2001a). In this disease, however, the mutations are foundT cells recognizing self antigens. Another group of disor-
in the LRRs of NOD2.ders, the autoinflammatory disorders, involve spon-
Since the NACHT domain plays a crucial role in proteintaneous inflammation without any apparent trigger or
oligomerization, it was likely that mutant NALP3 hadautoimmune etiology. The periodic fevers are autoin-
an increased propensity to oligomerize spontaneously,flammatory disorders that are characterized by sponta-
either because of defective binding of a regulatory pro-neous attacks of systemic inflammation and prolonged
tein or due to decreased interaction with the LRR ofepisodes of fever (Hull et al., 2003). The discovery that
NALP3, which is known to autoinhibit NALP3 activity bymany of the hereditary fever syndromes are attributable
binding to the NACHT domain (Agostini et al., 2004;to single gene effects was unexpected, since most of
Dowds et al., 2004; Tschopp et al., 2003). A model ofthe autoimmune disorders have complex etiologies
the structure of the NACHT of NALP3 based on thebased on multiple genes. These hereditary fever syn-
structure of crystalized AAA ATPases (Albrecht et al.,dromes include the Muckle Wells syndrome (MWS), fa-
2003) shows that the mutations are clustered on one
milial cold urticaria (FCU/FACS), chronic infantile neuro-
face of the predicted NACHT structure (Figure 4A), sug-
logical cutaneous and articular syndrome (CINCA,
gesting that this pocket-like region is essential for the
NOMID), familial Mediterranean fever (FMF), TNF-recep-
regulation of NALP3 activity.
tor-associated periodic fever syndrome (TRAPS), and In accord with this notion, constitutively elevated
hyperimmunoglobulinemia D with periodic fever syn- IL-1 maturation and secretion, even in the absence of
drome (HIDS). Characterization of the causative genetic LPS stimulation, was observed in a patient with MWS
defects turned out to be of great interest not only for the (Agostini et al., 2004). Moreover, overexpression of mu-
understanding of the molecular bases of inflammasome tant NALP3 proteins induces spontaneous IL-1 secre-
regulation, but also because it lead immediately to thera- tion (Dowds et al., 2004). Thus, the mutation in the
peutic approaches. NACHT motif can cause a high state of activation of the
MWS, FCU, and CINCA usually develop during child- inflammasome, suggesting that a single mutation in one
hood and are typically inherited as autosomal-dominant of the IL-1 inflammasome proteins results in local and
traits, but apparent sporadic cases also occur. In MWS, systemic inflammation. This hypothesis is clearly sup-
sensorineural deafness, rashes, and systemic amy- ported by the fact that administration of an IL-1 inhibitor
loidosis are observed and nonspecific limb pain is fre- (IL1-Ra, Anakinra) to MWS patients considerably attenu-
quent. FCU is characterized by skin lesions, swollen ates the disease symptoms (Hawkins et al., 2003). One
and painful joints, conjunctivitis, chills, and fever after of the first patients to receive the treatment had the
exposure to cold (Zip et al., 1993). The CINCA/NOMID R260W mutation (Hawkins et al., 2003). This patient dis-
syndrome presents very early in life with severe derma- played considerably reduced disease symptoms after
tologic, rheumatologic, and neurologic manifestations the first day of administrating the therapy. The surprising
associated with intense multisystem inflammation. Al- effect of the IL1-Ra in this patient clearly suggests that
though these syndromes were previously considered to the treatment directly targets the primary mediator of
be distinct clinical entities, it recently became clear that the autoinflammatory defect. The treatment is presently
they reflect a spectrum of diseases with CINCA patients being administered with comparable success to more
most severely affected. In fact, all syndromes are due than 20 patients with MWS or CINCA (Hawkins et al.,
to a mutation in the NALP3 gene. Four years ago, MWS 2004).
and FCU disease were mapped to chromosome 1q44 The gene(s) responsible for other autoinflammatory
diseases may also be linked to the control of inflamma-at a site that overlaps with the genomic localization of
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some activity (Figure 4C). For the familial Mediterranean the remaining NALPs also form complexes that lead to
the activation of inflammatory caspases. Since NALP7,fever, mutations in the gene product termed Pyrin were
identified in 1997 (French FMF, 1997; International FMF, 11, and 12 are predominantly expressed in immune cells,
their involvement in inflammasome formation is likely.1997). Targeted disruption of the C-terminal portion of
Pyrin in mice causes heightened sensitivity to endotoxin In contrast, expression of other NALPs (NALP5 and 8)
is restricted to germ cells, where they could fulfill otherand increased caspase-1 activation (Chae et al., 2003),
demonstrating the important role of this protein in in- functions. It will also be interesting to examine whether
mixed inflammasome complexes can be formed, for ex-flammation and probably in IL-1 maturation. The Pyrin
protein is characterized by the presence of an N-terminal ample containing proteins such as NALP3 and NALP12,
or even Ipaf. The broader question of the relative rolePYD and a C-terminal PRY-SPRY domain. Most of the
mutations in Pyrin affect the PRY-SPRY domain whose of the NALP inflammasome and Ipaf inflammasome will
be able to be addressed once the respective deficientfunction is currently unknown (Touitou, 2001). Pyrin in-
teracts with the inflammasome component ASC (Chae mice are available.
A major gap in our current understanding concernset al., 2003), suggesting a negative regulation of the
inflammatory response (Figure 4C). PSTPIP1(CD2BP), how the inflammasomes are activated. Only ATP and
LPS have been shown to be activators, but based onmutated in the inflammatory disease PAPA, was found
to bind to Pyrin and may be involved in the scaffolding the diversity of LRR-containing TLRs, it is likely that the
LRRs of NALPs and Ipaf detect a variety of distinctof inflammasome components to the cytoskeleton (Sho-
ham et al., 2003). bacterial and viral components. Another area where our
knowledge is clearly deficient relates to the role of cas-
pase-4 and caspase-12. No activating platform has beenConcluding Remarks
identified for these two caspases. Hopefully, answersThe molecular characterization of the complex that acti-
to at least some of these questions are just around thevates the inflammatory caspase-1 and caspase-5 has
corner since understanding how inflammatory caspasesrevealed a conserved activation mechanism of initiator
are activated and their activity attenuated will undoubt-caspases. Similar to the Apaf-1/apoptosome-mediated
edly shed more light on the role they play in inflammatoryactivation of caspase-9, activation of inflammatory cas-
disease pathogenesis.pases occurs through an oligomerizing molecular plat-
form—the NALP/inflammasome—that brings caspases
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